Zeynoc...
In your exuberance, you may have misread
Zeynoc...
In your exuberance, you may have misread Pluto's statement:
"Here are a couple of other thoughts. I have convinced KB as have others, to publish the Quarterly Report on time and not wait until the hearing. There will be a couple of things in that Quarterly Report, I think that might just identify that new partner everyone is asking about since the IVD world is awash with rumors. This partner is going to buy GenPrecis sight unseen. And, J&J is about to find out about another litigation front that will double Amazon sales thanks to a "friend" in Brooklyn, NY."
Pluto did not "convince him to disclose the name"
The "convincing" was to publish the quarterly report on time.
Just keeping all the ducks in proper formation....
I am...
*FULL OF SMILES*
Decision Diagnostics Corp (DECN) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Utility Solar Tracker Market Growth Prospects The utility solar tracker market is projected to reach an impressive USD 34.6 billion in the coming years. This growth is largely driven by the declining costs of photovoltaic (PV) panels, which have significantly lowered the financial barriers for solar energy projects. As PV panels become more affordable, the opportunity for...
Continue Reading
UVA Cancer Center Joins the Caris Precision Oncology Alliance UVA Cancer Center has officially joined the Caris Precision Oncology Alliance (Caris POA), a significant network dedicated to advancing precision medicine and cancer treatment. Caris Life Sciences is thrilled to welcome this esteemed institution, recognized for its commitment to enhancing patient outcomes...
Continue Reading
High-Rolling Investors Stake Their Bets on Spotify Technology In recent developments, it's evident that significant investors have adopted a bullish stance on Spotify Technology. This movement warrants attention from retail traders and those interested in stock market dynamics. Overview of Options Activity Tracking the latest trends, we've noted a remarkable surge in...
Continue Reading
Johnson & Johnson’s CAR T-Cell Therapy Demonstrates Promise in Lymphoma In a recent Phase 1b study, Johnson & Johnson (NYSE: JNJ) revealed the first clinical results of its investigational dual-targeting CAR T-cell therapy, JNJ-90014496, specifically aimed at treating patients with relapsed or refractory large B-cell lymphoma (R/R LBCL). This early data suggests a...
Continue Reading
Booking Holdings Set for Earnings Announcement Booking Holdings (NASDAQ: BKNG) is gearing up to share its quarterly earnings. Investors are keenly awaiting this announcement, which is expected to be significant for market sentiment and share price movements. Expected Earnings Per Share According to analysts, Booking Holdings is projected to report an impressive earnings...
Continue Reading